Zhejiang Ausun Pharmaceutical Co Ltd (603229) — Strategic Asset Allocation Index
Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a Strategic Asset Allocation Index of 48.2% as of June 2023. Strategic assets (PP&E of CN¥1.01 Billion plus long-term investments of CN¥-) total CN¥1.01 Billion, measured against net assets of CN¥2.10 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Zhejiang Ausun Pharmaceutical Co Ltd (603229) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Zhejiang Ausun Pharmaceutical Co Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Zhejiang Ausun Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 48.2%, representing strategic assets of CN¥1.01 Billion against net assets of CN¥2.10 Billion CNY. For live market cap and overall valuation, see 603229 company net worth.
Annual Strategic Asset Allocation Index for Zhejiang Ausun Pharmaceutical Co Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Ausun Pharmaceutical Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Zhejiang Ausun Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 65.1% | CN¥950.94 Million | CN¥950.94 Million | CN¥- | CN¥1.46 Billion | ▲ +17.2 pp |
| 2021 | 47.9% | CN¥601.46 Million | CN¥601.46 Million | CN¥- | CN¥1.25 Billion | ▲ +21.3 pp |
| 2020 | 26.6% | CN¥299.92 Million | CN¥299.92 Million | CN¥- | CN¥1.13 Billion | ▼ -11.5 pp |
| 2019 | 38.1% | CN¥245.82 Million | CN¥245.82 Million | CN¥- | CN¥645.19 Million | ▲ +0.0 pp |
| 2018 | 38.1% | CN¥227.55 Million | CN¥227.55 Million | CN¥- | CN¥597.60 Million | ▲ +3.9 pp |
| 2017 | 34.1% | CN¥192.80 Million | CN¥192.80 Million | CN¥- | CN¥564.93 Million | ▼ -34.6 pp |
| 2016 | 68.7% | CN¥167.23 Million | CN¥167.23 Million | CN¥- | CN¥243.30 Million | — |